Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer

2024; Elsevier BV; Volume: 86; Issue: 3 Linguagem: Inglês

10.1016/j.eururo.2024.03.014

ISSN

1873-7560

Autores

Cameron Englman, Davide Maffei, Clare Allen, Alex Kirkham, Peter C. Albertsen, Veeru Kasivisvanathan, Ronaldo Hueb Baroni, Alberto Briganti, Pieter De Visschere, Louise Dickinson, Juan Gómez Rivas, Masoom A. Haider, Claudia Kesch, Stacy Loeb, Katarzyna J. Macura, Daniel Margolis, Anita Mitra, Anwar R. Padhani, Valeria Panebianco, Peter A. Pinto, Guillaume Ploussard, Philippe Puech, Andrei S. Purysko, Jan Philipp Radtke, Antti Rannikko, Art Rastinehad, Raphaële Renard‐Penna, Francesco Sanguedolce, Lars Schimmöller, Ivo G. Schoots, Shahrokh F. Shariat, Nicola Schieda, Clare M. Tempany, Barış Türkbey, Massimo Valério, Arnauld Villers, Jochen Walz, Tristan Barrett, Francesco Giganti, Caroline M. Moore,

Tópico(s)

MRI in cancer diagnosis

Resumo

The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) recommendations standardise the reporting of prostate magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer. An international consensus group recently updated these recommendations and identified the areas of uncertainty.

Referência(s)